171 related articles for article (PubMed ID: 15485689)
1. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes.
Cheng X; Cheng XS; Kuo KH; Pang CC
Cardiovasc Res; 2004 Nov; 64(2):298-307. PubMed ID: 15485689
[TBL] [Abstract][Full Text] [Related]
2. The ruthenium-based nitric oxide scavenger, AMD6221, augments cardiovascular responsiveness to noradrenaline in rats with streptozotocin-induced diabetes.
Hutchings SR; Song D; Fricker SP; Pang CC
Eur J Pharmacol; 2005 Dec; 528(1-3):132-6. PubMed ID: 16310182
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
Nagareddy PR; McNeill JH; MacLeod KM
Eur J Pharmacol; 2009 Jun; 611(1-3):53-9. PubMed ID: 19344709
[TBL] [Abstract][Full Text] [Related]
4. The effect of N-acetylcysteine on cardiac contractility to dobutamine in rats with streptozotocin-induced diabetes.
Cheng X; Xia Z; Leo JM; Pang CC
Eur J Pharmacol; 2005 Sep; 519(1-2):118-26. PubMed ID: 16111676
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats.
Nagareddy PR; Xia Z; MacLeod KM; McNeill JH
J Cardiovasc Pharmacol; 2006 Apr; 47(4):513-20. PubMed ID: 16680064
[TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase depresses cardiac contractile function in Zucker diabetic fatty rats.
Song D; Kuo KH; Yao R; Hutchings SR; Pang CC
Eur J Pharmacol; 2008 Jan; 579(1-3):253-9. PubMed ID: 17976576
[TBL] [Abstract][Full Text] [Related]
7. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.
Kankuri E; Vaali K; Knowles RG; Lähde M; Korpela R; Vapaatalo H; Moilanen E
J Pharmacol Exp Ther; 2001 Sep; 298(3):1128-32. PubMed ID: 11504810
[TBL] [Abstract][Full Text] [Related]
8. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
[TBL] [Abstract][Full Text] [Related]
9. Increased vasoconstriction to noradrenaline by 1400W, inhibitor of iNOS, in rats with streptozotocin-induced diabetes.
Cheng X; Pang CC
Eur J Pharmacol; 2004 Jan; 484(2-3):263-8. PubMed ID: 14744612
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective iNOS inhibition on systemic hemodynamics and mortality rate on endotoxic shock in streptozotocin-induced diabetic rats.
Kadoi Y; Goto F
Shock; 2007 Nov; 28(5):602-9. PubMed ID: 17607161
[TBL] [Abstract][Full Text] [Related]
11. [The effect of nitrogen monoxide and its synthase on the diabetic retinal damage].
Liu QH; Xie P; Ge YB; Yuan XR
Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):837-41. PubMed ID: 16191353
[TBL] [Abstract][Full Text] [Related]
12. Altered vasodilator role of nitric oxide synthase in the pancreas, heart and brain of rats with spontaneous type 2 diabetes.
Song D; Yao R; Pang CC
Eur J Pharmacol; 2008 Sep; 591(1-3):177-81. PubMed ID: 18585382
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of iNOS with 1400W improves contractile function and alters nos gene and protein expression in reperfused skeletal muscle.
Patel P; Qi WN; Allen DM; Chen LE; Seaber AV; Stamler JS; Urbaniak JR
Microsurgery; 2004; 24(4):324-31. PubMed ID: 15274192
[TBL] [Abstract][Full Text] [Related]
14. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.
Jesmin S; Zaedi S; Maeda S; Yamaguchi I; Goto K; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):925-31. PubMed ID: 16741025
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury.
Li D; Qu Y; Tao L; Liu H; Hu A; Gao F; Sharifi-Azad S; Grunwald Z; Ma XL; Sun JZ
J Surg Res; 2006 Mar; 131(1):64-72. PubMed ID: 16154595
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing.
Guo JS; Cho CH; Wang JY; Koo MW
Eur J Pharmacol; 2006 May; 536(3):301-8. PubMed ID: 16600210
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor in diabetes induced early retinal abnormalities.
Cukiernik M; Hileeto D; Evans T; Mukherjee S; Downey D; Chakrabarti S
Diabetes Res Clin Pract; 2004 Sep; 65(3):197-208. PubMed ID: 15331199
[TBL] [Abstract][Full Text] [Related]
18. The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina.
Cukiernik M; Hileeto D; Downey D; Evans T; Khan ZA; Karmazyn M; Chakrabarti S
Diabetes Metab Res Rev; 2004; 20(1):61-71. PubMed ID: 14737747
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
Pérez-Asensio FJ; Hurtado O; Burguete MC; Moro MA; Salom JB; Lizasoain I; Torregrosa G; Leza JC; Alborch E; Castillo J; Knowles RG; Lorenzo P
Neurobiol Dis; 2005 Mar; 18(2):375-84. PubMed ID: 15686966
[TBL] [Abstract][Full Text] [Related]
20. Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts.
Felaco M; Grilli A; De Lutiis MA; Patruno A; Libertini N; Taccardi AA; Di Napoli P; Di Giulio C; Barbacane R; Conti P
Ann Clin Lab Sci; 2001 Apr; 31(2):179-86. PubMed ID: 11337908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
